SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 43.36 |
| Enterprise Value ($M) | -25.05 |
| Book Value ($M) | 68.15 |
| Book Value / Share | 2.20 |
| Price / Book | 0.64 |
| NCAV ($M) | 66.22 |
| NCAV / Share | 2.14 |
| Price / NCAV | 0.65 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.39 |
| Return on Assets (ROA) | -0.28 |
| Return on Equity (ROE) | -0.34 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 16.32 |
| Current Ratio | 16.32 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 70.83 |
| Assets | 72.76 |
| Liabilities | 4.61 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -30.19 |
| Net Income | -26.57 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -25.24 |
| Cash from Investing | -0.25 |
| Cash from Financing | 83.56 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | 5AM Partners VII, LLC | 36.40 | -1.74 | |
| 13G/A | Janus Henderson Group Plc | 0.00 | -100.00 | |
| 13G/A | Altium Capital Management LP | 4.30 | 1.05 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 60,580 | 182,092 | 33.27 | |
| 113,771 | 270,885 | 42.00 | |
| 40,578 | 86,594 | 46.86 | |
| 158,291 | 339,983 | 46.56 | |
| 184,764 | 413,386 | 44.70 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SCYX – SCYNEXIS, Inc. | SGMT – Sagimet Biosciences Inc. |
| SIGA – SIGA Technologies, Inc. | SMMT – Summit Therapeutics Inc. |
| SPRY – ARS Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io